Tamoxifen for breast cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Breast Cell Line, Tumor MCF-7 Cells Tumor Cells, Cultured Axilla Mammary Glands, Human Nipples Lymph Nodes Neoplastic Stem Cells Epithelial Cells Neoplastic Cells, Circulating Cell Line Mammary Glands, Animal

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases43

Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Neoplasm Metastasis Neoplasm Invasiveness Breast Neoplasms, Male Neoplasms, Hormone-Dependent Carcinoma, Lobular Carcinoma, Intraductal, Noninfiltrating Neoplasm Recurrence, Local Mammary Neoplasms, Experimental Lymphatic Metastasis Genetic Predisposition to Disease Carcinoma Ovarian Neoplasms Disease Progression Fibrocystic Breast Disease Lung Neoplasms Neoplasms Prostatic Neoplasms Endometrial Neoplasms Neoplasms, Second Primary Bone Neoplasms Carcinoma, Ductal Carcinoma in Situ Colonic Neoplasms Cell Transformation, Neoplastic Stomach Neoplasms Triple Negative Breast Neoplasms Adenocarcinoma Inflammatory Breast Neoplasms Pancreatic Neoplasms Fibroadenoma Neovascularization, Pathologic Uterine Cervical Neoplasms Neoplastic Cells, Circulating Hot Flashes Neoplasms, Basal Cell Mammary Neoplasms, Animal Neoplasms, Radiation-Induced Colorectal Neoplasms Neoplasms, Multiple Primary Carcinoma, Squamous Cell

Chemicals and Drugs63

Tamoxifen Antineoplastic Agents, Hormonal Receptors, Estrogen Estrogen Antagonists Receptor, erbB-2 Selective Estrogen Receptor Modulators Receptors, Progesterone Estrogen Receptor Modulators Aromatase Inhibitors Tumor Markers, Biological Estrogen Receptor alpha Antineoplastic Agents Estrogens Neoplasm Proteins Nitriles Estradiol Triazoles RNA, Messenger BRCA2 Protein Raloxifene Toremifene BRCA1 Protein Fluorouracil DNA, Neoplasm Cyclophosphamide Anticarcinogenic Agents RNA, Small Interfering Epirubicin Antibodies, Monoclonal, Humanized Cytochrome P-450 CYP2D6 Ki-67 Antigen Tumor Suppressor Protein p53 Receptor, Epidermal Growth Factor Antibodies, Monoclonal RNA, Neoplasm Tumor Suppressor Proteins Paclitaxel Aminoglutethimide Estrogen Receptor beta Cancer Vaccines Antigens, Neoplasm Transcription Factors Mucin-1 Methotrexate Antigens, CD24 Doxorubicin Antibiotics, Antineoplastic Anthracyclines MicroRNAs Proto-Oncogene Proteins c-akt DNA-Binding Proteins Cyclin D1 Estrone Proto-Oncogene Proteins Progestins Goserelin Cisplatin Enzyme Inhibitors Nuclear Proteins Protein-Serine-Threonine Kinases Nuclear Receptor Coactivator 3 Quinazolines Antineoplastic Agents, Phytogenic

Analytical, Diagnostic and Therapeutic Techniques and Equipment76

Mammography Chemotherapy, Adjuvant Prognosis Mastectomy Neoplasm Staging Risk Factors Early Detection of Cancer Antineoplastic Combined Chemotherapy Protocols Disease-Free Survival Survival Analysis Mammary Neoplasms, Experimental Follow-Up Studies Case-Control Studies Immunohistochemistry Risk Gene Expression Profiling Survival Rate Treatment Outcome Breast Self-Examination Risk Assessment Prospective Studies Reverse Transcriptase Polymerase Chain Reaction Mastectomy, Segmental Retrospective Studies Odds Ratio Incidence Blotting, Western Xenograft Model Antitumor Assays Cohort Studies Multivariate Analysis Neoplasm Transplantation Transplantation, Heterologous Registries Combined Modality Therapy Oligonucleotide Array Sequence Analysis Sensitivity and Specificity Predictive Value of Tests Tissue Array Analysis Kaplan-Meier Estimate Ultrasonography, Mammary Clinical Trials as Topic Drug Administration Schedule Logistic Models SEER Program Questionnaires Tumor Burden Transfection Breast Implants Radiotherapy, Adjuvant Neoadjuvant Therapy Mammaplasty Reproducibility of Results Proportional Hazards Models Polymerase Chain Reaction Drug Screening Assays, Antitumor Confidence Intervals Mass Screening Immunoenzyme Techniques Estrogen Replacement Therapy Neoplasm Grading Radiotherapy Genetic Testing Biopsy, Needle Biopsy Molecular Targeted Therapy Lymph Node Excision Sentinel Lymph Node Biopsy Gene Knockdown Techniques Mastectomy, Radical In Situ Hybridization, Fluorescence Ovariectomy Models, Biological DNA Mutational Analysis Hormone Replacement Therapy Randomized Controlled Trials as Topic Pilot Projects

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes50

Gene Expression Regulation, Neoplastic Postmenopause Drug Resistance, Neoplasm Premenopause Genes, BRCA1 Menopause Genetic Predisposition to Disease Breast Feeding Cell Proliferation Risk Genes, BRCA2 Odds Ratio Genes, erbB-2 Time Factors Apoptosis Signal Transduction Cell Division Mutation Dose-Response Relationship, Drug Genotype Sensitivity and Specificity Cell Movement Down-Regulation Polymorphism, Genetic Germ-Line Mutation Promoter Regions, Genetic Transfection Cell Growth Processes Cell Cycle DNA Methylation Gene Amplification RNA Interference Up-Regulation Cell Survival Gene Expression Gene Silencing Parity Phosphorylation Genes, Neoplasm Phenotype Drug Synergism Base Sequence Genes, Tumor Suppressor Epithelial-Mesenchymal Transition Genes, p53 Alleles Transcription, Genetic Diet Heterozygote Polymorphism, Single Nucleotide

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science7

Survival Rate Incidence Registries SEER Program Questionnaires Base Sequence Molecular Sequence Data

Named Groups3

Survivors European Continental Ancestry Group African Americans

Health Care33

Risk Factors Disease-Free Survival Survival Analysis Follow-Up Studies Case-Control Studies Risk Survival Rate Treatment Outcome Risk Assessment Prospective Studies Retrospective Studies Age Factors Odds Ratio Incidence Cohort Studies Multivariate Analysis Registries Sensitivity and Specificity Predictive Value of Tests Kaplan-Meier Estimate Clinical Trials as Topic Logistic Models SEER Program Questionnaires Reproducibility of Results Proportional Hazards Models Confidence Intervals Mass Screening Genetic Testing Parity National Cancer Institute (U.S.)Randomized Controlled Trials as Topic Pilot Projects

Geographicals2

United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Tamoxifen Breast Breast Neoplasms Antineoplastic Agents, Hormonal Receptors, Estrogen Carcinoma, Ductal, Breast Estrogen Antagonists Cell Line, Tumor Receptor, erbB-2 Breast Diseases Selective Estrogen Receptor Modulators Gene Expression Regulation, Neoplastic Postmenopause Receptors, Progesterone Mammography Chemotherapy, Adjuvant Estrogen Receptor Modulators Neoplasm Metastasis Prognosis Aromatase Inhibitors Neoplasm Invasiveness Tumor Markers, Biological Breast Neoplasms, Male Neoplasms, Hormone-Dependent Estrogen Receptor alpha Mastectomy Neoplasm Staging Drug Resistance, Neoplasm Antineoplastic Agents Estrogens Risk Factors Premenopause Early Detection of Cancer Neoplasm Proteins Genes, BRCA1 Carcinoma, Lobular Nitriles Antineoplastic Combined Chemotherapy Protocols Disease-Free Survival Estradiol Mice, Nude Survival Analysis MCF-7 Cells Carcinoma, Intraductal, Noninfiltrating Tumor Cells, Cultured Neoplasm Recurrence, Local Mammary Neoplasms, Experimental Menopause Lymphatic Metastasis Triazoles Genetic Predisposition to Disease Follow-Up Studies Carcinoma Case-Control Studies Immunohistochemistry Breast Feeding Cell Proliferation Risk Gene Expression Profiling Survival Rate Treatment Outcome Breast Self-Examination Ovarian Neoplasms Risk Assessment Prospective Studies Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger Mastectomy, Segmental Genes, BRCA2 BRCA2 Protein Retrospective Studies Raloxifene Toremifene BRCA1 Protein Age Factors Odds Ratio Disease Progression Axilla Fibrocystic Breast Disease Incidence Survivors Genes, erbB-2 Lung Neoplasms Time Factors Neoplasms Fluorouracil Mammary Glands, Human Blotting, Western DNA, Neoplasm Prostatic Neoplasms Apoptosis Xenograft Model Antitumor Assays Cohort Studies Signal Transduction Cyclophosphamide Multivariate Analysis Cell Division Mutation Neoplasm Transplantation Endometrial Neoplasms

No FAQ available that match "tamoxifen for breast cancer"